These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28954780)

  • 1. Outcomes of
    Koh WJ; Moon SM; Kim SY; Woo MA; Kim S; Jhun BW; Park HY; Jeon K; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Kim H; Kwon OJ
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28954780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
    Jhun BW; Moon SM; Kim SY; Park HY; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic Maintenance and Redevelopment of Nontuberculous Mycobacteria Pulmonary Disease after Treatment of Mycobacterium avium Complex Pulmonary Disease.
    Zo S; Kim H; Kwon OJ; Jhun BW
    Microbiol Spectr; 2022 Aug; 10(4):e0108822. PubMed ID: 35950873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.
    Moon SM; Jhun BW; Baek SY; Kim S; Jeon K; Ko RE; Shin SH; Lee H; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
    Respir Med; 2019 May; 151():1-7. PubMed ID: 31047103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease.
    Park S; Jo KW; Lee SD; Kim WS; Shim TS
    Respir Med; 2017 Dec; 133():36-41. PubMed ID: 29173447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease.
    Kwon YS; Koh WJ
    J Korean Med Sci; 2016 May; 31(5):649-59. PubMed ID: 27134484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease Progression in Patients With Nontuberculous Mycobacterial Lung Disease of Nodular Bronchiectatic (NB) Pattern: The Roles of Cavitary NB and Soluble Programmed Death Protein-1.
    Pan SW; Su WJ; Chan YJ; Ho ML; Feng JY; Shu CC; Wang JY; Wang HC; Yu CJ; Chen YM
    Clin Infect Dis; 2022 Aug; 75(2):239-247. PubMed ID: 34726741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing Epidemiology of Nontuberculous Mycobacterial Lung Diseases in a Tertiary Referral Hospital in Korea between 2001 and 2015.
    Ko RE; Moon SM; Ahn S; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Koh WJ
    J Korean Med Sci; 2018 Feb; 33(8):e65. PubMed ID: 29441757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redevelopment after spontaneous sputum conversion in noncavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
    Kim OH; Chong YP; Shim TS; Jo KW
    J Infect Chemother; 2021 Aug; 27(8):1156-1161. PubMed ID: 33745810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.
    Gochi M; Takayanagi N; Kanauchi T; Ishiguro T; Yanagisawa T; Sugita Y
    BMJ Open; 2015 Aug; 5(8):e008058. PubMed ID: 26246077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease.
    Asakura T; Nakagawa T; Suzuki S; Namkoong H; Morimoto K; Ishii M; Kurashima A; Betsuyaku T; Ogawa K; Hasegawa N;
    J Infect Chemother; 2019 Mar; 25(3):218-221. PubMed ID: 30172726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease.
    Kang HK; Park HY; Kim D; Jeong BH; Jeon K; Cho JH; Kim HK; Choi YS; Kim J; Koh WJ
    BMC Infect Dis; 2015 Feb; 15():76. PubMed ID: 25887191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and radiographic outcomes of nontuberculous mycobacterial lung disease in rheumatoid arthritis.
    Yamakawa H; Takayanagi N; Miyahara Y; Ishiguro T; Kanauchi T; Hoshi T; Yanagisawa T; Sugita Y
    J Rheumatol; 2013 Aug; 40(8):1307-15. PubMed ID: 23588941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.
    Moon SM; Park HY; Kim SY; Jhun BW; Lee H; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6758-6765. PubMed ID: 27572413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic treatment for nontuberculous mycobacterial lung disease.
    Kang YA; Koh WJ
    Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort.
    Zweijpfenning S; Kops S; Magis-Escurra C; Boeree MJ; van Ingen J; Hoefsloot W
    Respir Med; 2017 Oct; 131():220-224. PubMed ID: 28947034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of species change of Nontuberculous Mycobacteria during or after treatment.
    Lee JS; Lee JH; Yoon SH; Kim TS; Seong MW; Han SK; Yim JJ
    BMC Pulm Med; 2017 Dec; 17(1):213. PubMed ID: 29262802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease.
    Lee BY; Kim S; Hong Y; Lee SD; Kim WS; Kim DS; Shim TS; Jo KW
    Antimicrob Agents Chemother; 2015; 59(6):2972-7. PubMed ID: 25753634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.